Hologic announced today that it picked up a victory over Siemens Healthineers in the Unified Patent Court (UPC) in Germany.
Hologic, Inc., a global leader in women’s health, today released its 2025 Sustainability Report. The new report coincides ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a company that develops industry-leading technologies that detect, diagnose and treat life-changing health conditions that affect ...
The Unified Patent Court in Germany has ruled that Siemens Healthineers infringed on Hologic's mammography technology patent.
FDA warns of a breast biopsy needle shortage through March 2027 due to a Hologic recall. Learn how this affects patient care ...
Unified Patent Court (UPC) in Germany, which ruled that Siemens* infringed upon a critical Hologic mammography technology patent in Siemens' latest mammography system. The court imposed a sweeping ...
HOLX is expected to post Q1 EPS of $1.09 and revenues of $1.07B, both up year over year. Hologic's Diagnostics growth is driven by U.S. molecular tests, new assay clearances and Panther adoption. HOLX ...
The Food and Drug Administration said that the US is experiencing a shortage of breast biopsy needles after Hologic Inc. recalled the products earlier this year, potentially causing delays in ...
Hologic, Inc.’s robust strength in the Molecular Diagnostics business is poised to drive growth in the upcoming quarters. Solid demand for breast imaging solutions aids the Breast Health division’s ...
Hologic (HOLX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the ...
Hologic’s HOLX Molecular Diagnostics business posted a 7.8% (excluding COVID-19-related sales) growth in the second quarter of fiscal 2025, although results did not reflect its full potential.The ...
Report outlines actions helping to reduce environmental impact, advance health equity and engage a purpose-driven workforce Hologic, Inc., a global leader in women's health, today released its 2025 ...